Machine Learning for Multi-Disease Diagnostics Using Peptide Arrays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current disease diagnostic models are limited by their focus on single conditions and are not robust against data noise, lacking the ability to effectively predict multiple disease states and handle diverse peptide interactions.
Innovation Solution
The development of machine learning systems that utilize peptide sequence data and binding values from diverse peptide arrays, trained using neural networks and support vector machines, to create predictive models capable of identifying multiple disease states and conditions, with enhanced robustness to noise.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If current disease diagnostic models focus on single conditions, then they can achieve high accuracy for that specific condition, but they cannot effectively predict multiple disease states and are not robust against data noise
Solution Approach 1:
The patent applies universality by training a single machine learning model on peptide binding data from multiple diseases simultaneously, enabling the model to generalize across different disease states. The model learns universal patterns in antibody-peptide interactions that are applicable to various diseases, rather than requiring separate models for each condition.
Solution Approach 2:
The patent combines data from multiple diseases and peptide arrays into a unified training dataset. By merging diverse peptide sequences and binding values across different disease conditions, the model learns robust representations that are not overfit to any single disease, thereby improving noise robustness while maintaining multi-disease predictive capability.
2Loss of information
If diverse peptide arrays with many sequences are used, then the model can capture broader binding profiles and improve disease differentiation, but the data complexity and computational requirements increase
Solution Approach 1:
The patent extracts essential binding characteristics from large-scale peptide array data by focusing on the most informative peptide-antibody interactions. The machine learning model automatically identifies and weights the most discriminative features, extracting key binding profile information while filtering out redundant or noisy data points.
Solution Approach 2:
The patent transforms raw peptide sequence data into numerical representations suitable for machine learning processing. By converting amino acid sequences into numerical features and binding values into standardized formats, the complex biological data is transformed into a form that can be efficiently processed while preserving the essential binding information.
3Ease of manufacture
If traditional diagnostic methods are used, then the implementation is simple and well-established, but they lack the ability to learn complex relationships between various disease conditions
Solution Approach 1:
The patent replaces traditional statistical or rule-based diagnostic methods with a machine learning system. Instead of relying on pre-defined thresholds or simple comparisons, the system uses neural networks or other ML algorithms to automatically learn complex patterns and relationships in peptide binding data, enabling more sophisticated disease differentiation.
Solution Approach 2:
The patent performs preliminary training of the machine learning model on extensive peptide array data from multiple diseases before deployment. This pre-training phase allows the model to learn robust disease-specific patterns and relationships in advance, so that when deployed for actual diagnosis, it can immediately apply these learned relationships without requiring complex real-time adjustments.
Data Source
AI summary
Systems and methods for using machine learning to improve disease diagnostics are provided. A method can include obtaining, using a peptide array, peptide sequence data and peptide binding values from one or more samples, wherein the peptide sequence data and the peptide binding values correspond to a plurality of conditions; for each of the one or more samples, normalizing the peptide binding values according to a median binding value of peptides associated with the peptide array; and training a regressor using dense compact representations of the peptide sequence data and peptide binding values. The method can further include providing an output of the regressor to a classifier, wherein the classifier is configured to determine whether the patient has one of the plurality of conditions based on the output of the regressor.